Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimonabant effects on energy expenditure and fat metabolism in obesity
NCT00584389Phase 4Terminated
- Sponsor
- University of Surrey
- Start
- Jul 2007
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of rimonabant in obesity (2 arms), sponsored by University of Surrey. Primary endpoint: Direct effect of rimonabant on energy expenditure at 12 weeks. Started Jul 2007; status: terminated.
02
Drugs
rimonabant
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00584389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00584389.